Holen Sie sich die Stockscreener-App
279.66
1.30%
-3.7601
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CRM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$283.42
Offen:
$279
24-Stunden-Volumen:
2.24M
Relative Volume:
0.35
Marktkapitalisierung:
$268.27B
Einnahmen:
$37.90B
Nettoeinkommen (Verlust:
$6.20B
KGV:
43.97
EPS:
6.36
Netto-Cashflow:
$12.43B
1W Leistung:
-3.92%
1M Leistung:
+11.68%
6M Leistung:
-18.21%
1J Leistung:
+0.42%
1-Tages-Spanne:
$278.06
$280.46
1-Wochen-Bereich:
$278.06
$289.90
52-Wochen-Spanne:
$212.00
$369.00
Salesforce Inc Stock (CRM) Company Profile
Firmenname
Salesforce Inc
Sektor
Branche
Telefon
415-901-7000
Adresse
SALESFORCE TOWER, SAN FRANCISCO
Vergleichen Sie CRM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRM
Salesforce Inc
|
279.61 | 278.98B | 37.90B | 6.20B | 12.43B | 6.36 |
|
SAP
Sap Se Adr
|
294.71 | 343.39B | 37.72B | 6.14B | 5.67B | 5.2099 |
|
YMM
Full Truck Alliance Co Ltd Adr
|
11.12 | 13.05B | 1.57B | 427.90M | 0 | 0.4181 |
|
NOW
Servicenow Inc
|
1,007.31 | 214.26B | 11.47B | 1.54B | 3.63B | 7.36 |
|
INTU
Intuit Inc
|
717.16 | 184.88B | 17.17B | 3.04B | 5.63B | 10.72 |
Salesforce Inc Stock (CRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Herabstufung | DA Davidson | Neutral → Underperform |
| 2025-03-19 | Eingeleitet | Stephens | Equal-Weight |
| 2025-02-27 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-02-19 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-01-17 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-06 | Herabstufung | Guggenheim | Neutral → Sell |
| 2024-12-13 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-12-12 | Eingeleitet | Macquarie | Neutral |
| 2024-12-04 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-11-19 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-11-15 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-10-02 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2024-09-24 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-08-29 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-05-30 | Bestätigt | Oppenheimer | Outperform |
| 2024-03-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-01-11 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-12-21 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-12-18 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-11-30 | Bestätigt | BMO Capital Markets | Outperform |
| 2023-11-30 | Bestätigt | Needham | Buy |
| 2023-11-30 | Bestätigt | Oppenheimer | Outperform |
| 2023-10-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-09-15 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-31 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-01 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-02 | Hochstufung | Needham | Hold → Buy |
| 2023-01-20 | Herabstufung | Cowen | Outperform → Market Perform |
| 2023-01-18 | Eingeleitet | DA Davidson | Neutral |
| 2023-01-13 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2023-01-11 | Herabstufung | Bernstein | Mkt Perform → Underperform |
| 2022-12-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-12-02 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-11-17 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2022-11-02 | Fortgesetzt | Macquarie | Outperform |
| 2022-10-17 | Eingeleitet | Northland Capital | Market Perform |
| 2022-09-28 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-09-02 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-08-12 | Eingeleitet | Guggenheim | Sell |
| 2022-05-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-03-02 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-03-02 | Bestätigt | BofA Securities | Buy |
| 2022-03-02 | Bestätigt | Canaccord Genuity | Buy |
| 2022-03-02 | Bestätigt | Piper Sandler | Overweight |
| 2022-03-02 | Bestätigt | Raymond James | Strong Buy |
| 2022-03-02 | Bestätigt | Stifel | Buy |
| 2022-03-02 | Bestätigt | UBS | Neutral |
| 2022-03-02 | Bestätigt | Wedbush | Outperform |
| 2022-01-05 | Herabstufung | UBS | Buy → Neutral |
| 2021-11-22 | Fortgesetzt | Atlantic Equities | Overweight |
| 2021-11-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-11-02 | Eingeleitet | Deutsche Bank | Buy |
| 2021-09-24 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-09-24 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-09-20 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-26 | Bestätigt | Barclays | Overweight |
| 2021-08-26 | Bestätigt | Bernstein | Mkt Perform |
| 2021-08-26 | Bestätigt | BofA Securities | Buy |
| 2021-08-26 | Bestätigt | Canaccord Genuity | Buy |
| 2021-08-26 | Bestätigt | Citigroup | Neutral |
| 2021-08-26 | Bestätigt | Cowen | Outperform |
| 2021-08-26 | Bestätigt | Credit Suisse | Outperform |
| 2021-08-26 | Bestätigt | FBN Securities | Outperform |
| 2021-08-26 | Bestätigt | Mizuho | Buy |
| 2021-08-26 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-08-26 | Bestätigt | Oppenheimer | Outperform |
| 2021-08-26 | Bestätigt | Piper Sandler | Neutral |
| 2021-08-26 | Bestätigt | Stifel | Buy |
| 2021-08-26 | Bestätigt | UBS | Buy |
| 2021-07-16 | Fortgesetzt | Stifel | Buy |
| 2021-06-28 | Eingeleitet | Redburn | Buy |
| 2021-05-28 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-05-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-23 | Eingeleitet | Wolfe Research | Outperform |
| 2021-04-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-16 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-01-25 | Hochstufung | Loop Capital | Sell → Hold |
| 2021-01-22 | Eingeleitet | Goldman | Buy |
| 2021-01-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Fortgesetzt | BofA Securities | Buy |
| 2020-12-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-11-24 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-11-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-14 | Fortgesetzt | UBS | Buy |
| 2020-08-26 | Bestätigt | Barclays | Overweight |
| 2020-08-26 | Bestätigt | Citigroup | Buy |
| 2020-08-26 | Bestätigt | Cowen | Outperform |
| 2020-08-26 | Bestätigt | Credit Suisse | Outperform |
| 2020-08-26 | Bestätigt | JMP Securities | Mkt Outperform |
| 2020-08-26 | Bestätigt | Jefferies | Buy |
| 2020-08-26 | Bestätigt | Mizuho | Buy |
| 2020-08-26 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2020-08-26 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-08-26 | Bestätigt | Raymond James | Strong Buy |
| 2020-08-26 | Bestätigt | Stifel | Buy |
| 2020-08-26 | Bestätigt | Truist | Buy |
| 2020-08-26 | Bestätigt | Wedbush | Outperform |
| 2020-08-24 | Bestätigt | Barclays | Overweight |
Alle ansehen
Salesforce Inc Aktie (CRM) Neueste Nachrichten
Stocks to watch next week: Nvidia, Salesforce, Dell, Costco and Kingfisher - Yahoo
Salesforce.com (CRM) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo
Hackers expose 23 million Coca-Cola records in Salesforce attack - Cybernews
Zacks Investment Ideas feature highlights: Salesforce and Microsoft - Zacks Investment Research
We’re building a family, not just a programme: Sanket Atal on Salesforce’s start-up strategy - BusinessLine
Converge adopts Salesforce's Tableau agentic analytics platform for customer behavior monitoring - Telecompaper
Salesforce (CRM) and Indeed Team Up, Use AI Agents to Ease Hiring Workflows - Insider Monkey
Salesforce Launches Agentforce for Financial Services - Inc.com
July 3rd Options Now Available For Salesforce (CRM) - Nasdaq
Salesforce's Fiscal Q1 Seen Not Catalyzing New Opinions on Stock, Oppenheimer Says - marketscreener.com
Buy This Megacap Tech Stock Down 20% Before Earnings for AI Growth? - The Globe and Mail
Salesforce Gears Up to Post Q1 Earnings: How to Play the Stock? - The Globe and Mail
Salesforce, Inc. (CRM) Investor Outlook: Unveiling a 29% Potential Upside and Robust Cash Flows - DirectorsTalk Interviews
Steve Jobs Once Invited Marc Benioff To His Office With 2 iPads In 2010: The Lesson That Shaped A $270 Billion Salesforce Empire - Benzinga
Salesforce com : Forges Partnership with Bouygues Telecom to Place AI at the Heart of its Customer Relations - marketscreener.com
UBS Trims Salesforce (CRM) Target to $320, Cites No Surprise in Guidance - Insider Monkey
Alerus Selects SuperTRUMP for Salesforce - Monitordaily
3 Reasons Salesforce Could Be Back at All-Time Highs by June - MarketBeat
New Salesforce climate goals quietly lower bar - San Francisco Examiner
Is Salesforce Stock (NYSE:CRM) a Buy Now? Technical Indicators Suggest Yes - TipRanks
Salesforce (CRM) Target Price Lowered by UBS, Maintains Neutral Rating | CRM Stock News - GuruFocus
Salesforce.com (CRM) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Salesforce partner commentary on Q1 ‘slightly better’ than expected, says Stifel - TipRanks
UBS Adjusts Price Target on Salesforce to $320 From $340, Maintains Neutral Rating - marketscreener.com
Salesforce (CRM) Sees Positive Outlook as Flex Credit System Unveiled | CRM Stock News - GuruFocus
Salesforce to launch Agentforce for Financial Services agent templates - ARNnet
Salesforce targets a more human touch for financial services firms, with AI agents - SiliconANGLE
UBS Adjusts Price Target for Salesforce (CRM), Maintains Neutral Rating | CRM Stock News - GuruFocus
Salesforce launches Agentforce campaign with Rahul Dravid - afaqs!
Salesforce Launches Agentforce Campaign with Rahul Dravid - SMEStreet
Salesforce launches second phase of campaign featuring Rahul Dravid - bestmediainfo.com
Morepen Laboratories to Add 1,000 Employees to Salesforce, Targeting ₹1,000 Crore in Finished Dosages by 2030 - geneonline.com
SALESFORCE : UBS reiterates its Neutral rating - marketscreener.com
HTTPeak Launches “Lazy Admin,” an AI Solution That Saves Costs and Staff Hours, empowering business users with data insights and analysis in seconds, all via natural language - GlobeNewswire Inc.
Morgan Stanley Reiterates Overweight on Salesforce (CRM) Ahead of Earnings - Insider Monkey
Salesforce (NYSE:CRM) Expands Life Sciences Cloud With Takeda Partnership - simplywall.st
JMP Reiterates Outperform on Salesforce (CRM), Cites Agentforce Pricing Shift - Insider Monkey
Salesforce Earnings Preview: Can't Continue Kicking The Can Down The Road - Seeking Alpha
Takeda selects Salesforce Life Sciences Cloud for Customer Engagement - Yahoo Finance
Salesforce, GSA announce collaboration to lower price of Slack - Yahoo Finance
Salesforce cuts Slack price for US government, following Google - The Mercury News
Simpliigence Expands Its Footprint with a New Office Opening in Indiranagar, Bangalore - GlobeNewswire
Salesforce Introduces Agentforce Integration With Slack, Enabling Contextual AI Agents In Workflow - BW Businessworld
Salesforce: Cementing Leadership In A Potentially Explosive Niche - Seeking Alpha
ServiceNow moves into AI-powered customer management. Is it a threat to Salesforce? - CNBC
Salesforce introduces Agentforce in Slack - The Hindu
Salesforce, Rahul Dravid Kick Off New Campaign Highlighting AI-Driven Agentforce Solution - digital terminal
Rahul Dravid’s Second Innings at Salesforce Begins with Agentforce - Analytics India Magazine
Salesforce (NYSE:CRM) Expands Its Reach in Healthcare and Government Sectors - TipRanks
Salesforce (CRM) Offers Significant Discounts to U.S. Government - GuruFocus
Takeda partners with Salesforce for AI-powered healthcare engagement - FirstWord Pharma
Finanzdaten der Salesforce Inc-Aktie (CRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
8.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):